V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014759 | 270010583 | 1.58 | 78.4 | Curative (C) | 2016-04-03 | 2016-04-07 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270023558 | LOPP |
| 270014760 | 270010583 | 1.83 | 95 | Palliative (P) | 2016-11-14 | 2016-11-14 | CHLVPP PABLOE | N | N | 270023558 | R-GEM-P |
| 270014761 | 270010585 | 1.61 | 86 | Curative (C) | 2013-11-04 | 2014-01-24 | CYCLOPHOSPHAMIDE | 02 | Y | 270023584 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270014762 | 270010587 | 1.86 | 84.45 | Palliative (P) | 2015-06-29 | 2015-07-06 | Thalidomide 50mg | 2 | N | 270023586 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 270014763 | 270010588 | 1.68 | 92.1 | Curative (C) | 2014-02-25 | 2014-02-25 | ECHELON 1 TRIAL | N | N | 270023591 | LOPP |
| 270014764 | 270010588 | 1.68 | 69.9 | Curative (C) | 2013-09-25 | 2013-09-25 | IDELALISIB | N | N | 270023591 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014765 | 270010588 | null | null | Curative (C) | null | 2015-07-06 | Chlorambucil | N | null | 270023591 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 270014766 | 270010589 | 1.64 | 50.6 | Curative (C) | 2013-09-05 | 2013-09-05 | CHOP - 21 days | N | N | 270023657 | DHAP - R |
| 270014767 | 270014941 | 1.73 | null | Palliative (P) | 2014-07-18 | 2014-07-29 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + MESNA + RITUXIMAB | N | N | 270023661 | GEMCARBO |
| 270014768 | 270017241 | null | 88 | Palliative (P) | 2016-08-14 | 2017-04-26 | Methotrexate intrathecal | N | N | 270023661 | BENDAMUSTINE + RITUXIMAB |
| 270014769 | 270010593 | 1.83 | 58.2 | Curative (C) | 2016-04-09 | 2016-04-20 | CYCLOPHOSPHAMIDE | N | N | 270023690 | BORTEZOMIB |
| 270014770 | 270010595 | 1.75 | 62 | Curative (C) | 2013-04-17 | 2013-05-15 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 270023704 | CYCLOPHOSPHAMIDE |
| 270014771 | 270010595 | 1.62 | 57 | Curative (C) | 2017-04-09 | 2017-04-09 | METHOTREXATE | N | N | 270023704 | ICE-R |
| 270014772 | 270018547 | 1.57 | 82 | Disease modification (D) | 2013-09-24 | 2013-10-15 | ECHELON 1 TRIAL | N | N | 270023710 | CARBOPLATIN + CETUXIMAB + FU |
| 270014773 | 270010596 | 1.63 | 74 | Curative (C) | 2013-02-26 | 2013-03-07 | IDELALISIB | N | N | 270023757 | FLUDARABINE + MELPHALAN |
| 270014774 | 270010597 | 1.58 | 69 | null | 2015-01-10 | 2015-01-10 | RATHL TRIAL | 02 | N | 270023799 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270014775 | 270010597 | 1.62 | 67.8 | null | 2018-03-27 | 2018-04-04 | IGEV R | N | N | 270023799 | VINCRISTINE |
| 270014776 | 270010598 | 1.6 | 86.8 | Palliative (P) | 2014-05-13 | 2014-05-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270023805 | AFLIBERCEPT |
| 270014777 | 270010601 | null | 86 | Curative (C) | 2013-10-11 | 2013-10-14 | Imatinib 400mg | N | N | 270023835 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014778 | 270010603 | 1.78 | 52 | null | 2017-10-25 | 2017-11-15 | CVP R | 2 | N | 270023853 | METHOTREXATE INTRATHECAL |
| 270014779 | 270010603 | 1.6 | 75 | Curative (C) | 2014-03-08 | 2014-03-09 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270023853 | CHLVPP/PABLOE |
| 270014780 | 270010603 | 1.74 | 112.3 | Curative (C) | 2015-11-10 | 2015-11-17 | PACLITAXEL | N | N | 270023853 | ICE |
| 270014781 | 270010604 | 1.62 | 51.6 | Adjuvant (A) | 2017-12-21 | 2017-12-21 | BENDAMUSTINE + THALIDOMIDE | 02 | N | 270023880 | GDP R |
| 270014782 | 270017244 | null | 50.1 | Palliative (P) | 2017-04-25 | 2017-05-02 | Capecitabine + Mitomycin | N | N | 270023880 | BENDAMUSTINE + RITUXIMAB |
| 270014783 | 270010606 | 1.75 | 74.4 | null | 2017-07-03 | 2017-07-05 | DOXORUBICIN | 2 | N | 270023885 | FCR |
| 270014784 | 270010606 | 1.65 | null | Curative (C) | 2016-11-04 | 2016-12-02 | Dacarbazine | N | N | 270023885 | LACE |
| 270014785 | 270010607 | 1.72 | 84.5 | Neo-adjuvant (N) | 2013-06-18 | 2013-06-26 | Cisplatin + Etoposide + RT | N | N | 270023905 | CARBOPLATIN + RT |
| 270014787 | 270014950 | 1.76 | 60.6 | Curative (C) | 2016-08-15 | 2016-09-11 | IDELALISIB | N | N | 270023921 | METHOTREXATE INTRATHECAL |
| 270014788 | 270014950 | null | 102 | Palliative (P) | 2018-02-02 | 2018-02-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 270023921 | BENDAMUSTINE + BRENTUXIMAB |
| 270014789 | 270014950 | 1.75 | 79.5 | Disease modification (D) | 2017-02-08 | 2017-02-08 | Dacarbazine | 2 | N | 270023921 | METHOTREXATE INTRATHECAL |
| 270014790 | 270014950 | 1.76 | 60.6 | Neo-adjuvant (N) | 2015-07-11 | 2015-08-29 | Gemcitabine + Oxaliplatin | N | N | 270023921 | PMITCEBOM |
| 270014791 | 270010609 | null | 62.7 | Curative (C) | 2015-06-28 | 2015-07-09 | CVP | N | N | 270024022 | CLADRIBINE |
| 270014792 | 270014951 | 1.74 | 52 | null | 2014-10-24 | 2014-10-27 | GEMCITABINE + VINORELBINE | Y | N | 270024025 | CYCLOPHOSPHAMIDE |
| 270014793 | 270010611 | 1.66 | 58 | Neo-adjuvant (N) | 2016-12-16 | 2016-12-24 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270024032 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270014794 | 270010612 | null | null | Palliative (P) | 2013-03-24 | 2013-03-26 | Gemcitabine + Oxaliplatin | N | null | 270024039 | GEMCITABINE + OXALIPLATIN |
| 270014795 | 270010612 | null | null | T | 2017-04-06 | 2017-04-12 | R GCVP | N | N | 270024039 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270014796 | 270014953 | 1.7 | 55 | Curative (C) | null | 2016-03-23 | CARBOPLATIN + GEMCITABINE | N | N | 270024095 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 270014797 | 270014953 | 1.7 | 72 | null | 2016-01-17 | 2016-01-26 | Procarbazine | N | N | 270024095 | CVP R |
| 270014798 | 270010614 | 1.62 | 75.8 | Curative (C) | 2015-05-25 | 2015-06-02 | LENALIDOMIDE | N | null | 270024105 | NILOTINIB |
| 270014799 | 270010615 | 1.92 | null | Disease modification (D) | 2016-06-08 | 2016-06-16 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 270024115 | DACARBAZINE |
| 270014800 | 270018552 | null | null | Curative (C) | 2014-01-01 | 2014-01-16 | R GCVP | N | N | 270024127 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270014801 | 270010616 | 1.77 | 57 | Curative (C) | 2015-08-30 | 2015-09-13 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270024151 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014802 | 270010618 | null | 94 | Curative (C) | 2014-01-31 | 2014-01-31 | BLEOMYCIN | N | N | 270024176 | IVE-R |
| 270014803 | 270010618 | 0 | 74 | Curative (C) | 2013-12-04 | 2014-01-20 | LOPP | N | N | 270024176 | ICE |
| 270014804 | 270010619 | 1.65 | 71 | Curative (C) | 2013-09-28 | 2013-09-28 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE | N | N | 270024185 | CVP R |
| 270014805 | 270014958 | 1.82 | 79.5 | Curative (C) | 2018-05-15 | 2018-05-15 | BENDAMUSTINE + THALIDOMIDE | 02 | N | 270024186 | MPT |
| 270014806 | 270010620 | 1.48 | 86.2 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-02 | ETOPOSIDE | 02 | null | 270024192 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014807 | 270014960 | 1.79 | 82.4 | Curative (C) | 2014-11-10 | 2014-11-11 | Gemcitabine + Oxaliplatin | N | N | 270024194 | RUXOLITINIB |
| 270014808 | 270010623 | null | 80.2 | Curative (C) | 2017-11-29 | 2017-12-09 | BENDAMUSTINE + THALIDOMIDE | 02 | N | 270024204 | CYCLOPHOSPHAMIDE |
| 270014809 | 270010625 | 1.77 | 112.3 | Palliative (P) | 2017-03-08 | 2017-03-19 | ETOPOSIDE | N | N | 270024216 | CYCLOPHOSPHAMIDE + FLUDARABINE |